LIVN
LivaNova PLC (LIVN)
Healthcare • NASDAQ • $71.86+1.32%
- Symbol
- LIVN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $71.86
- Daily Change
- +1.32%
- Market Cap
- $3.95B
- Trailing P/E
- 36.66
- Forward P/E
- 15.49
- 52W High
- $72.51
- 52W Low
- $41.02
- Analyst Target
- $80.73
- Dividend Yield
- N/A
- Beta
- 0.82
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to ass…
Company websiteResearch LIVN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.